SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (17) , 4575-4579
- https://doi.org/10.1016/j.bmcl.2004.05.093
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Promising candidates for the treatment of chronic hepatitis CExpert Opinion on Investigational Drugs, 2003
- New therapies on the horizon for hepatitis C: are we close?Clinics in Liver Disease, 2003
- Design and Synthesis of Potent, Non-peptide Inhibitors of HCV NS3 ProteaseBioorganic & Medicinal Chemistry Letters, 2003
- Glycine α-Ketoamides as HCV NS3 Protease InhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- Recent developments in the discovery of hepatitis C virus serine protease inhibitors – towards a new class of antiviral agents?Expert Opinion on Investigational Drugs, 2003
- Capped dipeptide α-Ketoacid inhibitors of the HCV NS3 proteaseBioorganic & Medicinal Chemistry Letters, 2002
- Hepatitis C therapeutics: current status and emerging strategiesNature Reviews Drug Discovery, 2002
- Treatment of chronic hepatitis C with PEGylated interferon and ribavirinCurrent Gastroenterology Reports, 2002
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001
- The Scientific Challenge of Hepatitis CScience, 1999